Accelerating the iMpact of microsurgEry by upscaling production of thE world’s first microsurgical roboT: MUSA

Introduction

The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company, is introducing MUSA, the world’s first clinically available CE-certified microsurgical robot.

Objectives

We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers.

Efficiency and Cost Reduction

The MUSA robot is highly efficient, thereby reducing costs and improving access to microsurgical procedures.

Market Readiness

With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes.

Project Goals

In this project, we will tackle the remaining bottlenecks for successful rollout of the product, including:

1. Upscaling
2. Optimizing manufacturability

This will allow for rapid market uptake of MUSA after the project.

Future Plans

MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.